Home » Topics » Regulatory

Regulatory
RSS

FDA grants accelerated approval for Ibrance in advanced breast cancer

Feb. 4, 2015

FDA approves Glyxambi for type 2 diabetes

Feb. 3, 2015

FDA approves first drug for Waldenstrom's macroglobulinemia

Feb. 2, 2015

FDA approves Vyvanse for binge eating disorder

Feb. 2, 2015

FDA approves Bristol-Myers Squibb's Evotaz for HIV-1 infection

Jan. 30, 2015

FDA approves Triferic for iron replacement and hemoglobin maintenance in CKD

Jan. 27, 2015

FDA approves Natpara for treatment of hypocalcemia in patients with hypoparathyroidism

Jan. 27, 2015

China approves Epidaza for peripheral T-cell lymphoma

Jan. 13, 2015

Cosentyx approved in Japan for psoriasis and psoriatic arthritis

Dec. 30, 2014

Takecab approved for the treatment of acid-related diseases in Japan

Dec. 30, 2014